Long-term treatment with the Na+-glucose cotransporter inhibitor T-1095 causes sustained improvement in hyperglycemia and prevents diabetic neuropathy in Goto-Kakizaki Rats

This publication has 28 references indexed in Scilit:

• Improved diabetic syndrome in C57BL/KsJ‐db/db mice by oral administration of the Na⁺‐glucose cotransporter inhibitor T‐1095
  British Journal of Pharmacology, 2001
• T-1095, a renal Na+-glucose transporter inhibitor, improves hyperglycemia in streptozotocin-induced diabetic rats
  Metabolism, 2000
• Improved glucose tolerance restores insulin-stimulated Akt kinase activity and glucose transport in skeletal muscle from diabetic Goto-Kakizaki rats
  Diabetes, 1997
• Insulin-induced activation of glycerol-3-phosphate acyltransferase by a chiro-inositol-containing insulin mediator is defective in adipocytes of insulin-resistant, type II diabetic, Goto-Kakizaki rats.
  Proceedings of the National Academy of Sciences, 1994
• Relative effects of calorie restriction and weight loss in noninsulin- dependent diabetes mellitus
  The Journal of Clinical Endocrinology & Metabolism, 1993
• The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus
  New England Journal of Medicine, 1993
• Pathogenesis of NIDDM: A Balanced Overview
  Diabetes Care, 1992
• Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
  Diabetologia, 1985
• Neuro‐endocrine disorders seen as triggers of the triad: Obesity—insulin resistance—abnormal glucose tolerance
  Diabetes/Metabolism Research and Reviews, 1985
• Impaired insulin secretion in the spontaneous diabetes rats.
  The Tohoku Journal of Experimental Medicine, 1982